Legal & General Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Legal & General Group’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,023	Closed	-$55K	–	3460
2019 Q2	$55K	Hold	4,023	–	–	﹤0.01%	2734
2019 Q1	$69K	Hold	4,023	–	–	﹤0.01%	2613
2018 Q4	$51K	Hold	4,023	–	–	﹤0.01%	2688
2018 Q3	$65K	Hold	4,023	–	–	﹤0.01%	2654
2018 Q2	$52K	Sell	4,023 -780	-16%	-$10.5K	﹤0.01%	2729
2018 Q1	$60K	Sell	4,803 -1,688	-26%	-$20.5K	﹤0.01%	2671
2017 Q4	$91K	Sell	6,491 -784	-11%	-$11.5K	﹤0.01%	2629
2017 Q3	$124K	Buy	7,275 +905	+14%	+$14.7K	﹤0.01%	2531
2017 Q2	$106K	Hold	6,370	–	–	﹤0.01%	2579
2017 Q1	$98K	Sell	6,370 -70	-1%	-$1K	﹤0.01%	2555
2016 Q4	$96K	Buy	+6,440	New	+$90.4K	﹤0.01%	2593

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Legal & General Group's OXFD Position: Q3 2019 in Review

Legal & General Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 4,023 shares — an estimated $55K sold.

Legal & General Group first reported a position in OXFD in Q4 2016 and held it in 11 quarters. The position peaked at $124K in Q3 2017. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

Legal & General Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Legal & General Group sold 4,023 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $55K.
Legal & General Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 11 quarters.
Legal & General Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $124K in Q3 2017.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.